Clinical Trials Directory

Trials / Sponsors / HanAll BioPharma Co., Ltd.

HanAll BioPharma Co., Ltd.

Industry · 16 registered clinical trials — 1 currently recruiting.

StatusTrialPhaseStarted
RecruitingEfficacy and Safety of Leuprolide Acetate 45 mg in Subjects With Central Precocious Puberty
CPP
Phase 42024-12-12
SuspendedA Study to Evaluate the Efficacy and Safety of Tanfanercept (HL036) in Dry Eye Disease
Dry Eye
Phase 32024-05-01
CompletedA Study Assessing the Safety of Oral ATH-399A in Healthy Adult Participants
Healthy Volunteers
Phase 12023-09-19
CompletedA Study to Assess the Efficacy and Safety of Tanfanercept (HL036) Ophthalmic Solution in Participants With Dry
Dry Eye
Phase 32021-11-18
CompletedA Study to Assess Efficacy and Safety of HL036 in Subjects With Dry Eyes
Dry Eye
Phase 32019-03-10
CompletedA Study to Assess Efficacy of HL036 in Subjects With Dry Eyes
Dry Eye
Phase 22017-11-05
CompletedBioequivalence Study (Candesartan 16 mg and Amlodipine 10 mg)
Hypertension
Phase 12016-12-14
CompletedPhase 1 Study for Safety and Tolerability of HL036
Dry Eye
Phase 12016-02-01
CompletedSafety and Pharmacokinetics Study of amlodipine10mg and candesartan32mg
Hypertension
Phase 12012-12-01
CompletedPharmacokinetic Interactions and Safety Study of Telmisartan and Chlorthalidone
Hypertension
Phase 12012-11-01
CompletedPhase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis
Mild to Moderate Atopic Dermatitis
Phase 22012-04-09
CompletedA Study to Evaluate Pharmacokinetics and Potential Drug Interactions of a Fixed-dose Combination Tablet, HL-04
Hypertension, Hyperlipidemia
Phase 12012-04-01
CompletedEfficacy and Safety of HL-040XC in Essential Hypertension and Hyperlipidemia
Essential Hypertension, Hyperlipidemia
Phase 32012-03-01
CompletedSafety, Pharmacokinetics and Pharmacodynamics Study of HL-032 in Healthy Male Volunteers
Growth Hormone Deficiency
Phase 12011-09-01
CompletedA Phase 1b/2a Study of SC Hanferon™ in Combination With Ribavirin in Treatment-naïve Subjects With Genotype 1
Chronic Hepatitis C Infection, Genotype 1
Phase 1 / Phase 22011-06-23
CompletedEfficacy and Safety Study of ELIGARD 22.5mg With Prostate Cancer
Prostate Cancer
Phase 42011-01-01